← All organizations

BiondVax Pharmaceuticals

For profitWebsite ↗

Also known as: BiondVax Pharmaceuticals ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 31, 2018

Defunct as of Dec 31, 2018

Timeline

2000s

Jun 1, 2003
BiondVax Pharmaceuticals— Founded

2010s

Dec 31, 2018
BiondVax Pharmaceuticals— Defunct

Drugs by trial phase (10 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

m-001 influenza vaccine

Phase 2 (9 own, 0 via acquisition)

Indications

Studied for

Influenza, Human

Recent trials (9)

NCT03450915Lead sponsorPhase 3Aug 31, 2018
NCT03450915Study directorPhase 3Aug 31, 2018
NCT02691130Lead sponsorPhase 2Nov 1, 2015
NCT02293317Study chairPhase 2Nov 1, 2014
NCT02293317Lead sponsorPhase 2Nov 1, 2014
NCT01419925Lead sponsorPhase 2Aug 1, 2011
NCT01146119Lead sponsorPhase 2Jul 1, 2010
NCT01010737Lead sponsorPhase 1/Phase 2Sep 1, 2009
NCT00877448Lead sponsorPhase 1/Phase 2Jun 1, 2009

Details

Founded: Ness Ziona, HaMerkaz, IL Jun 1, 2003
Last known activity: Aug 31, 2018